antiPLA2R Positive
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) (NCT04733040) | HI-Bio, A Biogen Company | 2021-01-20 |
| Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NCT04145440) | HI-Bio, A Biogen Company | 2019-10-15 |
Track antiPLA2R Positive automatically
Every clearance here is in the API, with alerts when new ones post.